Supplementary Table S3 from Cell Context Is the Third Axis of Synergy for the Combination of ATR Inhibition and Cisplatin in Ewing Sarcoma
Authors:
- Jennifer JessJJJennifer Jess
- Katie M. SorensenKSKatie M. Sorensen
- Elissa A. BoguslawskiEBElissa A. Boguslawski
- Matthew C. StoutMSMatthew C. Stout
- Zachary B. MadajZMZachary B. Madaj
- Benjamin P. CaielloBCBenjamin P. Caiello
- Monica PomavilleMPMonica Pomaville
- Elizabeth R. WilsonEWElizabeth R. Wilson
- Seneca S. Kinn-GurzoSKSeneca S. Kinn-Gurzo
- Curtis C. ParkerCPCurtis C. Parker
- Sridhar M. VeluvoluSVSridhar M. Veluvolu
- Taylor V. BrysgelTBTaylor V. Brysgel
Open Access
- 15 August 2024
- other
- Published by American Association for Cancer Research (AACR)